CUV 2.48% $14.05 clinuvel pharmaceuticals limited

Ann: Appendix 4C - quarterly, page-15

  1. 892 Posts.
    lightbulb Created with Sketch. 237
    That makes CUV #1 on list as Netwealth has 61% of equity in director/family hands and Promedicus 56%. These holdings are excluded from mkt cap for ASX200 purposes.

    The other aspect is that mkt cap is calculated based on the average mkt cap over the previous 6 months. CUV has had an appreciating share price so the mkt cap under consideration is less than current mkt cap. Nevertheless discretion can be applied.

    Before a company can be added, another has to drop out. This should occur in March and hopefully CUV will be #1 on the list to be added. Find out on 8 March.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.05
Change
0.340(2.48%)
Mkt cap ! $703.5M
Open High Low Value Volume
$13.90 $14.20 $13.71 $727.8K 51.88K

Buyers (Bids)

No. Vol. Price($)
1 167 $13.98
 

Sellers (Offers)

Price($) Vol. No.
$14.06 789 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.